FDA Inspection
RenatiLabs IncRenatiLabs Inc – FDA Inspection, Aug 12, 2022
Record Details
This FDA Inspection record concerns RenatiLabs Inc, with an inspection on August 12, 2022, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- RenatiLabs Inc
- Inspection Date
- August 12, 2022
- Product Type
- Biologics
View Company Profile
ID · 4b329d57-34b6-4df2-9704-3780941b9f89
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1177711
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.